Who is sponsoring NCT00872573?

NCT00872573 is sponsored by DePuy International.

What drugs are being tested in NCT00872573?

Interventions in NCT00872573: C-Stem™ AMT Femoral Component (standard and high off-set variants).

What condition does NCT00872573 study?

NCT00872573 studies Rheumatoid Arthritis, Osteoarthritis, Post-traumatic Arthritis, Collagen Disorders, Avascular Necrosis, Traumatic Femoral Fractures, Nonunion of Femoral Fractures, Congenital Hip Dysplasia, Slipped Capital Femoral Epiphysis.

Is NCT00872573 still recruiting?

NCT00872573 is currently terminated. Last updated 26 June 2017.

Last reviewed 2017-06-26 · How we verify

NCT00872573

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Two Centre Study to Assess the Stability and Long-term Performance of the C-Stem™ AMT in a Total Primary Hip Replacement

Terminated Phase 4 Last updated 26 June 2017

What this trial tests

Phase 4 trial testing C-Stem™ AMT Femoral Component (standard and high off-set variants) in Rheumatoid Arthritis in 5 participants. Terminated before completion.

Timeline

1 July 2006

Primary endpoint
1 October 2007

1 October 2007

Quick facts

Lead sponsor	DePuy International
Phase	Phase 4
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	5
Start date	1 July 2006
Primary completion	1 October 2007
Estimated completion	1 October 2007
Sites	1 location across United Kingdom

Drugs / interventions tested

C-Stem™ AMT Femoral Component (standard and high off-set variants)

Conditions studied

Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
Osteoarthritis — all drugs for Osteoarthritis →
Post-traumatic Arthritis — all drugs for Post-traumatic Arthritis →
Collagen Disorders — all drugs for Collagen Disorders →

Sponsor

DePuy International — full company profile →

Who can join

Adults 60 to 80, any sex, with Rheumatoid Arthritis or Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to monitor the stability of the C-Stem™ AMT hip within the thigh bone when used in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical, standard x-ray assessments and special x-rays which allow the stability of the implant to be determined.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rheumatoid Arthritis

Currently open trials in the same condition.

NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting

Other DePuy International trials

Trials by the same sponsor.

NCT01754363 — Survivorship of Attune Primary Total Knee Prosthesis · NA · active not recruiting
NCT01635166 — Multi-centre Study to Assess the Long-term Performance of the Deltamotion Cup System in Primary Hip Replacement Surgery · Phase 4 · terminated
NCT01418378 — Sigma CR150 Versus Sigma CR Knee RCT · Phase 4 · completed
NCT01134445 — An Electronic Data Capture Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Repl · Phase 4 · terminated
NCT00733499 — A Study to Determine the Difference in Low Contact Stress (LCS) Duofix Versus Low LCS Porocoat Knee Systems · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00872573 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by DePuy International
Last refreshed: 26 June 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00872573.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing